医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Ruyi Zhenbao Pills for Patients with Motor and Sensory Dysfunction after Stroke:A Double-Blinded,Randomized Placebo-Controlled Clinical Trial

摘要Objective:To evaluate the efficacy and safety of Tibetan medicine Ruyi Zhenbao Pills(RZPs)in the treatment of patients with motor and sensory dysfunction after stroke.Methods:A total of 120 convalescent stroke patients hospitalized in the Rehabilitation Department of Guangdong Provincial Hospital of Chinese Medicine from June 2017 to December 2019 were enrolled in this trial.Patients were assigned to control(60 cases)and research(60 cases)groups by computer random assignment.All patients received internal treatment and modem rehabilitation training.On this basis,the research group was given oral RZPs for 4 weeks,while the control group was given oral placebo.The primary outcome was motor function of the affected side evaluated by simplified Fugl-Meyer Motion Assessment Scale(FMA-M).The secondary outcomes included sensory function,activity of daily living(ADL),quality of life,balance function,and pain,which were assessed by Fugl-Meyer Sensory Assessment Scale(FMA-S),Modified Barthel Index(MBI),Special Scale of the Quality of Life(SS-QOL),Berg Balance Scale(BBS),and Visual Analogue Scale(VAS),respectively.All of the assessments were performed before treatment,and 4 and 8 weeks after treatment.Vital signs,liver and kidney functions,routine blood test,blood coagulation profile,and routine urinalysis of patients were monitored.Results:After 4-week treatment,the FMA-M,BBS and FMA-S scores in the research group significantly increased compared with the control group(P<0.05).At 8-week follow-up,the BBS and MBI scores in the research group were higher than the control group(P<0.05).There was no statistical difference between the 2 groups in the SS-QOL and VAS scores at 4 and 8 weeks(P>0.05).Moreover,after treatment,there was no significant difference in vital signs,liver and kidney functions,blood coagulation function,blood routine and urinalysis between the 2 groups(P>0.05).Conclusion:RZPs improved limb motor,balance,and sensory functions of stroke patients during recovery period with good safety.(Trial registration No.NCT04029701)

更多
广告
作者 LING Shan-shan [1] PAN Rui-huan [1] ZHAN Le-chang [1] LI Mei [1] YANG Zhi-jing [1] YANG Hao-dong [2] CHEN Hong-xia [1] 学术成果认领
作者单位 Department of Rehabilitation,The Second Affiliated Hospital,Guangzhou University of Chinese Medicine,Guangzhou 510120,China [1] The Second Institute of Clinical Medicine,Guangzhou University of Chinese Medicine,Guangzhou 510120,China [2]
栏目名称
DOI 10.1007/s11655-022-3577-9
发布时间 2022-11-10(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览9
  • 下载0
中国结合医学杂志(英文版)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷